Barbara Tevelev

Senior Scientist, Molecular Discovery, Cell Line Development, Bioprocess Research and Development at Pfizer

Barbara Tevelev is a Senior Scientist in the Cell Line Development group at Pfizer’s Biopharma Research and Development Organization. Barbara’s focus is developing and assessing cell lines for monoclonal antibodies and multi-specifics for Phase I projects. She is also responsible for performing phenotypic and genotypic characterization in support of late stage commercial suitability assessment. Some of Barbara’s most recent accomplishments have been centered around developing a new strategy for LIVCA, addressing regulatory concerns, as well as evaluating and streamlining workflows for development and production of complex modalities.